The Intersection of Life Sciences and Business

Back Bay teams begin with a nuanced understanding of the clinical and scientific underpinnings of new therapeutics and medical technologies. To this, we add our expertise in business and financial markets, as well as our knowledge of what drives R&D, commercial and transactional success.

We partner with clients to create actionable strategies for product development, commercial success and transactional execution that drive growth and create value across the product and corporate continuum. Our recommendations balance the needs of the patient, the vision of the company and returns for the investor, to provide workable solutions to the complex decision-making demanded by scientific and clinical innovation.

We have successfully completed more than 1,000 engagements spanning every phase of the product life cycle — from gleam-in-the-eye technologies to billion-dollar brands. We take pride in the number of clients who refer and re-engage us as new challenges emerge in the dynamic fields of life science and medical technology.

For every strategy engagement, Back Bay dedicates senior leadership and highly-experienced teams who have broad, diverse life science experience. Our teams communicate consistently and efficiently to provide insightful strategies to companies of all sizes, tackling challenges that range from early-stage candidates to leading brands across the biopharmaceutical and medical technology sectors.

From Johnson & Johnson to Centrexion, from Novo Nordisk to Albireo, across every sector, stage and geography, Back Bay Life Science Advisors partners with the organizations that sustain and grow the life science industry.

SELECT PROJECT AND
TRANSACTION HIGHLIGHTS

We’re pleased to provide a snapshot of some of our recent transactions and projects.

DOWNLOAD TRANSACTION HIGHLIGHT PDF >

Look to Back Bay experts for:

  • Franchise, business unit & therapeutic area strategy

  • Competitive intelligence

  • Asset & development prioritization

  • Platform implementation

  • Payor/Pricing strategy

  • Contracting strategy

  • Launch & counter-launch strategy

  • Product positioning, branding & messaging

  • Life-cycle management

  • Corporate growth strategy

  • Liquidity & exit planning

 
 
BackBayLifeScienceAdvisors_272449485.jpeg

Strategic Advisory for Biotech, Pharmaceutical and MedTech

 
growth.png

Business strategy for biotech enzyme manufacturing

An enzyme manufacturing company requested support to transition into clinical therapeutic protein development using their novel platform technology.

APPROACH

  • Using case studies, we evaluated the breadth of strategies (both success and failures) employed by platform companies to monetize their technology, including an understanding of relative risk, investment, timeline and potential return associated with each strategy
  • We built consensus among key company stakeholders around the optimal near-term business strategy for development of its therapeutics platform
  • Following this consensus, Back Bay comprehensively analyzed and prioritized all possible biologic therapeutic sectors addressable by the client’s novel platform technology using a range of metrics, including clinical feasibility, competitive intensity, unmet need and commercial attractiveness

RESULT

The client's management team is actively moving forward in recommended areas for in-house and partnering initiatives laid out by Back Bay.

Back Bay continues to actively engage with the management team on business strategy, new pharma hires, interpretation of key preclinical data, etc.

We helped develop a business partnering deck and coach management team in preparation for a large bio-partnering conference.

report.png

Growth Strategies for reproductive health pharmaceutical firm

An established reproductive health (RH) client requested help evaluating strategic “Beyond the Pill” options outside of the pharmaceutical landscape to expand its presence in the RH market.

APPROACH

  • We defined possible growth areas adjacent to the reproductive health pharmaceutical business using analysis of the combined fertility clinic workflow and fertility patient journey, including medical and physical exam related diagnostics

  • Our team eavlauated eight different strategic growth opportunities based on market opportunity, competition, unmet needs, fit with company business model, availability of assets, etc.

  • Back Bay prioritized the strategic growth opportunities based on key assessment criteria and further analyzed the most attractive opportunities for further consideration

  • We developed business cases for each high-priority opportunity, including value proposition, key risks, capabilities needed and possible M&A opportunities in the near and long term.

RESULT

Our analysis led to final recommendations for next steps, including both short-term and long-term strategic expansion.

Additionally, Back Bay has continued to support the diligence of relevant BD opportunities for this client.